Fox Chase Cancer Center Research Technician and Postdoctoral Fellow Receive AACR Minority Scholar Award in Cancer Research
PHILADELPHIA (March 23, 2004) -- A Fox Chase Cancer Center research technician and a postdoctoral fellow have each been selected by the American Association for Cancer Research (AACR) to receive a 2004 AACR Minority Scholar Award in Cancer Research. Minority scientists who are full-time graduate students, medical students, residents, clinical or postdoctoral fellows or junior faculty members are eligible for these highly competitive awards. The two honorees from Fox Chase Cancer Center are Monique A. Gary of Jenkintown, Pa., and Elizabeth A. Hopper-Borge, PhD, of Philadelphia's Chestnut Hill section.
Recipients receive a complimentary registration to the 95th AACR Annual Meeting in Orlando, Fla., as well as a stipend for meals and travel. Participation in such professional meetings is critical to career development, to collaborative research relationships and to learning about the very latest in cancer research.
Monique A. Gary is pursuing a master's degree in biomedical sciences at the Philadelphia College of Osteopathic Medicine. She currently works as a scientific technician in the Fox Chase laboratory of cell biologist Margie Clapper, PhD.
"I am honored to receive this award," Gary said. "The AACR meeting will expose me to a wide spectrum of cancer research and afford me the opportunity to interface with and learn from highly respected scientists. It will strengthen my commitment to advance cancer research and prevention during my career."
Gary volunteers in the community outreach department at Fox Chase, visiting health fairs and other community events to promote cancer screening and awareness.
"Cancer has affected more than one member of my family and I am passionate about cancer awareness, prevention and early detection. It can help save lives," she said. Elizabeth Hopper-Borge, PhD, is a postdoctoral fellow in the laboratory of medical oncologist Gary D. Kruh, MD, PhD. Hopper-Borge conducts research on a class of proteins that play a role in mechanisms of anticancer drug resistance.
"I am honored to have received this award because it will allow me the opportunity to interact with world-class scientists and learn from their experiences," Hopper-Borge said.
A grant from the National Cancer Institute's Comprehensive Minority Biomedical Program supports the awards.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.